Cargando…
Stability and Species Specificity of Renal VEGF-A Splicing Patterns in Kidney Disease
Vascular endothelial growth factor A (VEGF-A) is essential for maintaining the glomerular filtration barrier. Absolute renal levels of VEGF-A change in patients with diabetic nephropathy and inflammatory kidney diseases, but whether changes in the renal splicing patterns of VEGF-A play a role remain...
Autores principales: | Turner, R. J., Eikmans, M., Bajema, I. M., Bruijn, J. A., Baelde, H. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012578/ https://www.ncbi.nlm.nih.gov/pubmed/27598902 http://dx.doi.org/10.1371/journal.pone.0162166 |
Ejemplares similares
-
The VEGF-A inhibitor sFLT-1 improves renal function by reducing endothelial activation and inflammation in a mouse model of type 1 diabetes
por: Bus, Pascal, et al.
Publicado: (2017) -
Endoglin Is an Important Mediator in the Final Common Pathway of Chronic Kidney Disease to End-Stage Renal Disease
por: Gerrits, Tessa, et al.
Publicado: (2022) -
MIF Increases sFLT1 Expression in Early Uncomplicated Pregnancy and Preeclampsia
por: Yong, Qing, et al.
Publicado: (2023) -
The VEGF Inhibitor Soluble Fms-like Tyrosine Kinase 1 Does Not Promote AKI-to-CKD Transition
por: van Aanhold, Cleo C. L., et al.
Publicado: (2022) -
Modulation of VEGF-A Alternative Splicing as a Novel Treatment in Chronic Kidney Disease
por: Stevens, Megan, et al.
Publicado: (2018)